{"id":55217,"date":"2023-03-27T16:08:28","date_gmt":"2023-03-27T14:08:28","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/"},"modified":"2023-03-27T16:08:28","modified_gmt":"2023-03-27T14:08:28","slug":"namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/","title":{"rendered":"NAMSA Expands MedTech Portfolio in Market Intelligence and Customer Research Services through its Acquisition of EU-Based SUAZIO"},"content":{"rendered":"
\n

TOLEDO, Ohio & ANTWERP, Belgium–(BUSINESS WIRE)–#CRO<\/a>—NAMSA<\/a>, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of SUAZIO<\/a>, an EU-based strategic consultancy providing global market research services to medical device and IVD developers.\n<\/p>\n

<\/a><\/p>\n

\nFounded in 2001 in Antwerp, Belgium, SUAZIO\u2019s mission is to provide market insights to the MedTech industry across the globe through its data, people and analytics solutions<\/a>. The organization develops custom frameworks for each Client based on specific market needs, technology value drivers, patient journeys, digital healthcare environments and economic value propositions. Keeping each stakeholder\u2019s perspective in mind, this research results in robust data and accurate interpretation leading to clear recommendations and strategies for successful market introductions.\n<\/p>\n

\n\u201cNAMSA is very enthusiastic to expand its global strategic consulting services with the addition of SUAZIO,\u201d commented Dr. Christophe Berthoux<\/a>, NAMSA CEO. \u201cClient insights and precise market research are what power the true value of novel medical technologies and product acceptance. With the SUAZIO Team, NAMSA will expand its Client reach even further and strengthen the delivery of its full continuum development services to the global MedTech industry,\u201d Dr. Berthoux concluded.\n<\/p>\n

\nNAMSA\u2019s other consulting services<\/a> include Biological Safety, Quality, Regulatory, Reimbursement and Product Development Strategy. These teams are led by the MedTech industry\u2019s foremost experts, many of whom have held positions with the U.S. Food and Drug Administration (FDA), EU Notified Bodies and APAC authorities. NAMSA Consultants, who communicate with global government entities daily, are uniquely qualified to provide wide-ranging consulting services across the product development spectrum. NAMSA\u2019s proven services<\/a> and outcomes ultimately allow Clients to get to market faster and make a more immediate impact on patient safety and global healthcare.\n<\/p>\n

\n\u201cSUAZIO has sought to extend its reach within the MedTech ecosystem for some time and we could not be more thrilled to join NAMSA in its mission to deliver best-in-class global MedTech solutions through our people, expertise and technology,\u201d stated SUAZIO CEO, Christophe Van der Linden. \u201cWith similar values and experience in providing insights to accelerate MedTech innovation, our services are well-aligned to truly deliver global Clients end-to-end development and commercialization solutions that lead to success.\u201d\n<\/p>\n

\nThe acquisition of SUAZIO increases NAMSA\u2019s global presence to 20 locations<\/a> across the Americas, Asia and Europe.\n<\/p>\n

\nThe price and terms of the transaction are undisclosed.\n<\/p>\n

\nABOUT NAMSA<\/span><\/b>\n<\/p>\n

\nHelping medical device Sponsors improve healthcare since 1967, NAMSA is the world\u2019s leading MedTech Contract Research Organization (CRO) offering global end-to-end development services. Driven by its global regulatory expertise and in-depth therapeutic knowledge, NAMSA is dedicated to accelerating medical device product development, offering only the most proven solutions to move Clients\u2019 products through the development lifecycle efficiently and cost-effectively. From medical device testing; regulatory, reimbursement and quality consulting; and clinical research services, NAMSA is the industry\u2019s premier, trusted partner for successful development and commercialization outcomes.\n<\/p>\n

\nWeb: www.namsa.com<\/a>\n<\/p>\n

\nAbout SUAZIO<\/span><\/b>\n<\/p>\n

\nSUAZIO is a research and consultancy agency that provides far-reaching customer insights considering the marketing of new products in MedTech and IVD markets. For more than 20 years we have learned that the success of a product isn\u2019t exclusively built on the problem it solves. Our focus is entirely on the life sciences and we have the expertise to provide insights and solutions in many categories. We strive to create a work environment that fosters innovative out-of-the-box thinking and we aim to develop long-term relationships with both clients and employees.\n<\/p>\n

\nWeb: www.suazio.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nNAMSA Media Contact<\/span><\/b>
Leah Davidson, MA, MBA, PCM
\n
Sr. Manager, Global Marketing Communications
\n
Email: ldavidson@namsa.com<\/a>\n<\/p>\n

\nSUAZIO Media Contact<\/span><\/b>
Christophe Van der Linden
\n
Chief Executive Officer
\n
Email: c.vanderlinden@suazio.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TOLEDO, Ohio & ANTWERP, Belgium–(BUSINESS WIRE)–#CRO—NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of SUAZIO, an EU-based strategic consultancy providing global market research services to medical device and IVD developers. Founded in 2001 in Antwerp, Belgium, SUAZIO\u2019s mission is to provide market insights to the MedTech … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55217","6":"format-standard","7":"category-industry"},"yoast_head":"\nNAMSA Expands MedTech Portfolio in Market Intelligence and Customer Research Services through its Acquisition of EU-Based SUAZIO - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NAMSA Expands MedTech Portfolio in Market Intelligence and Customer Research Services through its Acquisition of EU-Based SUAZIO - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TOLEDO, Ohio & ANTWERP, Belgium–(BUSINESS WIRE)–#CRO—NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of SUAZIO, an EU-based strategic consultancy providing global market research services to medical device and IVD developers. Founded in 2001 in Antwerp, Belgium, SUAZIO\u2019s mission is to provide market insights to the MedTech ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-27T14:08:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230327005036\/en\/667069\/21\/NamsaLogo-1.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"NAMSA Expands MedTech Portfolio in Market Intelligence and Customer Research Services through its Acquisition of EU-Based SUAZIO\",\"datePublished\":\"2023-03-27T14:08:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\\\/\"},\"wordCount\":626,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230327005036\\\/en\\\/667069\\\/21\\\/NamsaLogo-1.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\\\/\",\"name\":\"NAMSA Expands MedTech Portfolio in Market Intelligence and Customer Research Services through its Acquisition of EU-Based SUAZIO - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230327005036\\\/en\\\/667069\\\/21\\\/NamsaLogo-1.jpg\",\"datePublished\":\"2023-03-27T14:08:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230327005036\\\/en\\\/667069\\\/21\\\/NamsaLogo-1.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230327005036\\\/en\\\/667069\\\/21\\\/NamsaLogo-1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NAMSA Expands MedTech Portfolio in Market Intelligence and Customer Research Services through its Acquisition of EU-Based SUAZIO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NAMSA Expands MedTech Portfolio in Market Intelligence and Customer Research Services through its Acquisition of EU-Based SUAZIO - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/","og_locale":"en_US","og_type":"article","og_title":"NAMSA Expands MedTech Portfolio in Market Intelligence and Customer Research Services through its Acquisition of EU-Based SUAZIO - Pharma Trend","og_description":"TOLEDO, Ohio & ANTWERP, Belgium–(BUSINESS WIRE)–#CRO—NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of SUAZIO, an EU-based strategic consultancy providing global market research services to medical device and IVD developers. Founded in 2001 in Antwerp, Belgium, SUAZIO\u2019s mission is to provide market insights to the MedTech ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-27T14:08:28+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230327005036\/en\/667069\/21\/NamsaLogo-1.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"NAMSA Expands MedTech Portfolio in Market Intelligence and Customer Research Services through its Acquisition of EU-Based SUAZIO","datePublished":"2023-03-27T14:08:28+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/"},"wordCount":626,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230327005036\/en\/667069\/21\/NamsaLogo-1.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/","url":"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/","name":"NAMSA Expands MedTech Portfolio in Market Intelligence and Customer Research Services through its Acquisition of EU-Based SUAZIO - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230327005036\/en\/667069\/21\/NamsaLogo-1.jpg","datePublished":"2023-03-27T14:08:28+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230327005036\/en\/667069\/21\/NamsaLogo-1.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230327005036\/en\/667069\/21\/NamsaLogo-1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/namsa-expands-medtech-portfolio-in-market-intelligence-and-customer-research-services-through-its-acquisition-of-eu-based-suazio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"NAMSA Expands MedTech Portfolio in Market Intelligence and Customer Research Services through its Acquisition of EU-Based SUAZIO"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55217"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55217\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}